[Treatment of acute myocardial infarction--an elucidative report].
The present-day optimal treatment of patients with acute myocardial infarction (AMI) is reviewed. The prehospital phase should be as brief as possible. Emergency observation and treatment in hospital should be initiated without delay. Schematic stages for mobilization have been discarded and free mobilization is recommended. Routine acute intervention with thrombolysis is recommended for patients in whom symptoms have been present for 6-12 hours and treatment with Aspirin is recommended. Beta-blocking agents are recommended for patients with increased risk after discharge. Treatment of ventricular and supraventricular arrhythmias, block and cardiac failure are reviewed in detail. Patients without complications should be monitored for three to five days and may be discharged after seven to ten days. Exercise ECG should be carried out at discharge to assess the working capacity, ischaemia and subjective reaction. The importance of good patient information is emphasized. Cessation of smoking, control of lipids and blood pressure are important as secondary interventions. As far as possible, outpatient control should be offered after discharge. The criteria for referral to specialized cardiological departments are established both for emergency and elective referral. Patients under the age of 70 years with high risk for repeated AMI or death after discharge (with residual ischaemia) should possibly be referred for coronary arteriography.
Madsen
E B
EB
Godtfredsen
J
J
Hansen
J F
JF
Jensen
G
G
Nielsen
B L
BL
Nielsen
P E
PE
Nielsen
T T
TT
Pedersen
A
A
Rømer
F
F
Sandøe
E
E
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007902:Length of Stay; D009203:Myocardial Infarction / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*; D010353:Patient Education as Topic; D012307:Risk Factors; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D005343:Fibrinolytic Agents
Behandling af akut myokardieinfarkt--en klaringsrapport.